294 related articles for article (PubMed ID: 14993131)
1. Elevated levels of activin A in heart failure: potential role in myocardial remodeling.
Yndestad A; Ueland T; Øie E; Florholmen G; Halvorsen B; Attramadal H; Simonsen S; Frøland SS; Gullestad L; Christensen G; Damås JK; Aukrust P
Circulation; 2004 Mar; 109(11):1379-85. PubMed ID: 14993131
[TBL] [Abstract][Full Text] [Related]
2. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.
Dahl CP; Husberg C; Gullestad L; Waehre A; Damås JK; Vinge LE; Finsen AV; Ueland T; Florholmen G; Aakhus S; Halvorsen B; Aukrust P; Oie E; Yndestad A; Christensen G
Circ Heart Fail; 2009 Nov; 2(6):624-32. PubMed ID: 19919988
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure.
Ueland T; Yndestad A; Øie E; Florholmen G; Halvorsen B; Frøland SS; Simonsen S; Christensen G; Gullestad L; Aukrust P
Circulation; 2005 May; 111(19):2461-8. PubMed ID: 15883214
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of thrombospondin-1 in failing hearts may favor ventricular remodeling.
Batlle M; Pérez-Villa F; Lázaro A; García-Pras E; Vallejos I; Sionis A; Castel MA; Roig E
Transplant Proc; 2009; 41(6):2231-3. PubMed ID: 19715883
[TBL] [Abstract][Full Text] [Related]
5. Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistry.
Hofland J; van Nederveen FH; Timmerman MA; Korpershoek E; de Herder WW; Lenders JW; Verhofstad AA; de Krijger RR; de Jong FH
Clin Endocrinol (Oxf); 2007 Mar; 66(3):335-40. PubMed ID: 17302865
[TBL] [Abstract][Full Text] [Related]
6. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
[TBL] [Abstract][Full Text] [Related]
7. Glomerular activin A overexpression is linked to fibrosis in anti-Thy1 glomerulonephritis.
Gaedeke J; Boehler T; Budde K; Neumayer HH; Peters H
Nephrol Dial Transplant; 2005 Feb; 20(2):319-28. PubMed ID: 15673690
[TBL] [Abstract][Full Text] [Related]
8. Potential anti-inflammatory role of activin A in acute coronary syndromes.
Smith C; Yndestad A; Halvorsen B; Ueland T; Waehre T; Otterdal K; Scholz H; Endresen K; Gullestad L; Frøland SS; Damås JK; Aukrust P
J Am Coll Cardiol; 2004 Jul; 44(2):369-75. PubMed ID: 15261933
[TBL] [Abstract][Full Text] [Related]
9. Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure.
Husberg C; Nygård S; Finsen AV; Damås JK; Frigessi A; Oie E; Waehre A; Gullestad L; Aukrust P; Yndestad A; Christensen G
J Mol Cell Cardiol; 2008 Aug; 45(2):261-9. PubMed ID: 18585734
[TBL] [Abstract][Full Text] [Related]
10. Activin A is an acute allergen-responsive cytokine and provides a link to TGF-beta-mediated airway remodeling in asthma.
Karagiannidis C; Hense G; Martin C; Epstein M; Rückert B; Mantel PY; Menz G; Uhlig S; Blaser K; Schmidt-Weber CB
J Allergy Clin Immunol; 2006 Jan; 117(1):111-8. PubMed ID: 16387593
[TBL] [Abstract][Full Text] [Related]
11. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats.
Deten A; Hölzl A; Leicht M; Barth W; Zimmer HG
J Mol Cell Cardiol; 2001 Jun; 33(6):1191-207. PubMed ID: 11444923
[TBL] [Abstract][Full Text] [Related]
12. Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction.
Tsujita K; Kaikita K; Hayasaki T; Honda T; Kobayashi H; Sakashita N; Suzuki H; Kodama T; Ogawa H; Takeya M
Circulation; 2007 Apr; 115(14):1904-11. PubMed ID: 17389263
[TBL] [Abstract][Full Text] [Related]
13. Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype.
Yue P; Long CS; Austin R; Chang KC; Simpson PC; Massie BM
J Mol Cell Cardiol; 1998 Aug; 30(8):1615-30. PubMed ID: 9737947
[TBL] [Abstract][Full Text] [Related]
14. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction.
Maekawa Y; Anzai T; Yoshikawa T; Sugano Y; Mahara K; Kohno T; Takahashi T; Ogawa S
J Am Coll Cardiol; 2004 Oct; 44(7):1510-20. PubMed ID: 15464336
[TBL] [Abstract][Full Text] [Related]
15. Chromogranin B in heart failure: a putative cardiac biomarker expressed in the failing myocardium.
Røsjø H; Husberg C; Dahl MB; Stridsberg M; Sjaastad I; Finsen AV; Carlson CR; Oie E; Omland T; Christensen G
Circ Heart Fail; 2010 Jul; 3(4):503-11. PubMed ID: 20519641
[TBL] [Abstract][Full Text] [Related]
16. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair.
Tsuneyoshi H; Nishina T; Nomoto T; Kanemitsu H; Kawakami R; Unimonh O; Nishimura K; Komeda M
Circulation; 2004 Sep; 110(11 Suppl 1):II174-9. PubMed ID: 15364859
[TBL] [Abstract][Full Text] [Related]
18. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene.
Nishikimi T; Hagaman JR; Takahashi N; Kim HS; Matsuoka H; Smithies O; Maeda N
Cardiovasc Res; 2005 Apr; 66(1):94-103. PubMed ID: 15769452
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide induced activin A-follistatin imbalance affects cardiac fibrosis.
Zhang WQ; Yang CY; Li SM; Liu M; Ding M; Liu GH; Yang P
Chin Med J (Engl); 2012 Jun; 125(12):2205-12. PubMed ID: 22884154
[TBL] [Abstract][Full Text] [Related]
20. Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling.
Gurantz D; Yndestad A; Halvorsen B; Lunde OV; Omens JH; Ueland T; Aukrust P; Moore CD; Kjekshus J; Greenberg BH
Cardiovasc Res; 2005 Jul; 67(1):106-15. PubMed ID: 15949474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
